Boehringer Ingelheim’s Metalyse Approved in China for Acute Ischemic Stroke
Germany-based pharmaceutical leader Boehringer Ingelheim announced receiving marketing approval from China’s National Medical Products Administration...
Product approvals
GSK’s Blenrep Receives Marketing Approval in Japan for Multiple Myeloma
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) announced that it has received marketing approval from...
Hainan Shuangcheng’s Generic Eptifibatide Gains TGA Marketing Approval in Australia
China’s Hainan Shuangcheng Pharmaceutical Co., Ltd (SHE: 002693) has received marketing approval from Australia’s Therapeutic...
Stryker’s OptaBlate BVN System Gains FDA 510(k) Clearance
US-based Stryker (NYSE: SYK) announced this week that its OptaBlate Basivertebral Nerve Ablation (BVN) system...
Bayer’s Jivi Receives FDA Approval for Pediatric Hemophilia A Treatment
German pharmaceutical giant Bayer AG (ETR: BAYN) announced this week that it has received an...
Shanghai MicroPort’s Minos Stent Graft Secures Egyptian Marketing Approval
China’s Shanghai MicroPort Endovascular MedTech Co., Ltd (SHA: 688016) has announced that it has received...
Sino Biopharmaceutical’s QP001 (Meloxicam) Approved by NMPA and FDA for Postoperative Pain
China-based Sino Biopharmaceutical Ltd (HKG: 1177) announced that its Category 2.2 drug QP001 (meloxicam) has...
FDA Approves Merck’s Welireg for Locally Advanced or Metastatic Pheochromocytoma and Paraganglioma
The US Food and Drug Administration (FDA) announced this week an indication extension approval for...
Beijing Balance Medical’s Renato System Gets NMPA Approval for Valve-in-Valve Therapy
China’s Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has obtained market authorization from China’s...
Haisco Pharma’s HSK21542 Approved by NMPA for Post-Abdominal Surgery Pain
Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) has announced that it has received marketing approval...
Lifetech Scientific’s Aortic Arch Stent System Approved by China’s NMPA
China-based Lifetech Scientific Corporation (HKG: 1302) has announced that it has received marketing approval from...
Sihuan Pharmaceutical’s Bireociclib Approved by NMPA for Advanced Breast Cancer
China’s Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) announced that the National Medical Products Administration...
CANbridge’s Velaglucerase β Approved by NMPA for Gaucher’s Disease Long-Term Therapy
China-based CANbridge Pharmaceuticals Inc. (HKG: 1228) announced that the National Medical Products Administration (NMPA) has...
Novartis’ Scemblix Approved by NMPA for Newly Diagnosed Ph+ CML-CP Patients
Swiss pharmaceutical company Novartis (NYSE: NVS) announced that it has received marketing approval from China’s...
AbbVie’s Emrelis Granted FDA Accelerated Approval for NSCLC with High c-MET Overexpression
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to AbbVie’s (NYSE: ABBV)...
Novartis’ Kisqali Receives NMPA Approval for High-Risk Early Breast Cancer
Switzerland-based Novartis (NYSE: NVS) announced this week that it has received another indication approval from...
Roche’s VENTANA MET (SP44) RxDx Assay Gains FDA Approval for NSQ-NSCLC Patients
Swiss giant Roche (SWX: ROG, OTCMKTS: RHHBY) announced that the FDA has approved the VENTANA®...
Sinovac Biotech Gains Hong Kong Approval for Influenza Vaccines
China-based Sinovac Biotech Ltd (NASDAQ: SVA) announced that it has received marketing approvals from the...
United Imaging Healthcare Gains FDA Approval for uAngio AVIVA Interventional X-ray System
China-based United Imaging Healthcare (UIH, SHA: 688271) announced that it has received marketing approval from...
AstraZeneca’s Trixeo Aerosphere Wins UK Approval for COPD
UK-based pharmaceutical giant AstraZeneca (AZ; NASDAQ: AZN) announced this week that it has received marketing...